!! History Commons Alert, Exciting News

Context of '(Between July 2001 and May 2004): US Health Official Blocks Reports that Contradict Drug Industry Claims'

This is a scalable context timeline. It contains events related to the event (Between July 2001 and May 2004): US Health Official Blocks Reports that Contradict Drug Industry Claims. You can narrow or broaden the context of this timeline by adjusting the zoom level. The lower the scale, the more relevant the items on average will be, while the higher the scale, the less relevant the items, on average, will be.

President Bush appoints Ann-Marie Lynch as deputy assistant secretary in the office of policy at the Department of Health and Human Services. [US Congress, 7/25/2002, pp. 86 pdf file; Denver Post, 5/23/2004] One of Lynch’s responsibilities is to decide which topics are researched and which reports are released. She previously worked as a lobbyist for the drug- company trade group Pharmaceutical Research and Manufacturers of America where she fought congressional efforts to implement price controls on prescription drugs. She had argued that price caps would discourage medical innovation. [Denver Post, 5/23/2004] During her tenure at DHHS, Lynch’s division will publish a report praising brand-name drugs and warning that “restrictions on the coverage of new drugs could put the future of medical innovation at risk and may retard advances in treatment” (see July 2002). She will also block the release of several completed research reports that challenge drug-company claims (see (Between July 2001 and May 2004)).

Entity Tags: Ann-Marie Lynch, George W. Bush

Timeline Tags: US Health Care

Ann-Marie Lynch, deputy assistant secretary in the office of policy at the Department of Health and Human Services, allegedly blocks the release of several government reports that contradict claims made by the drug industry. One of them is a 2001 report stating that involvement of private health companies in Medicare’s prescription-drug benefit programs would lead to higher prices and would not work well in rural areas. [Denver Post, 5/23/2004]

Entity Tags: Ann-Marie Lynch

Timeline Tags: US Health Care

The Office of Policy at the US Department of Health and Human Services (DHHS) releases a report concluding that the US government should not impose price caps on prescription drugs. According to the report, doing so “could put the future of medical innovation at risk and may retard advances in treatment.” [US Department of Health and Human Services, 7/2002, pp. 2 pdf file] The deputy assistant secretary of the division, Ann-Marie Lynch, had used the same argument when she was a drug industry lobbyist (see June 2001) fighting against congressional efforts to cap drug prices. [Denver Post, 5/23/2004] Critics of the report say its conclusions are contradicted by the experiences of other countries that have remained innovative despite price controls. DHHS officials “haven’t taken as seriously their job of making medicines affordable to all Americans,” says Gail Shearer, director of health policy analysis for Consumers Union. According to critics, the report plays a role in the passing of Bush’s Medicare drug plan that prohibits the government from using its buying power to negotiate lower prices from the drug companies.

Entity Tags: Ann-Marie Lynch, US Department of Health and Human Services

Timeline Tags: US Health Care

The Associated Press reports that questions remain about how Army Private Jessica Lynch was injured (see March 23, 2003 and April 1, 2003). While US military doctors are reporting that Lynch did not suffer from gunshot wounds as originally reported (see April 4, 2003), the Associated Press report reads in part: “Lynch’s family in West Virginia said doctors had determined she’d been shot. They found two entry and exit wounds ‘consistent with low-velocity, small-caliber rounds,’ said her mother, Deadra Lynch.” [Project for Excellence in Journalism, 6/23/2003]

Entity Tags: Jessica Lynch, Associated Press, Deadra Lynch

Timeline Tags: Domestic Propaganda

Bank of America concludes an agreement to buy the troubled financial services company Merrill Lynch. Bank of America will pay Merrill Lynch’s shareholders in shares, offering stock worth $29 per one share in Merrill Lynch, which is 70 percent more than Merrill Lynch’s current market price. The sale follows a 68 percent decline in Merrill Lynch’s share price during the year amid writedowns and credit losses of $52bn. [Agency France-Presse, 9/15/2008; Bloomberg, 9/15/2008]

Entity Tags: Bank of America, Merrill Lynch

Timeline Tags: Global Economic Crises

Ordering 

Time period


Email Updates

Receive weekly email updates summarizing what contributors have added to the History Commons database

 
Donate

Developing and maintaining this site is very labor intensive. If you find it useful, please give us a hand and donate what you can.
Donate Now

Volunteer

If you would like to help us with this effort, please contact us. We need help with programming (Java, JDO, mysql, and xml), design, networking, and publicity. If you want to contribute information to this site, click the register link at the top of the page, and start contributing.
Contact Us

Creative Commons License Except where otherwise noted, the textual content of each timeline is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike